Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized tolerability study of AS-AQ Winthrop versus Coartem for uncomplicated falciparum malaria in Liberia
ISRCTN40020296Phase 4Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Malaria comparing Artesunate-amodiaquine Winthrop FDC with Coartem (2 arms). Primary endpoint: Clinical tolerability. Started Sep 2008; status: completed.
02
Drugs
artesunate + amodiaquinelumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN40020296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40020296.